REDEFINE Triple Defense

UNIISPL

Last synced from FDA National Drug Code directory (United States) on June 3, 2026

Identification

ManufacturerRodan & Fields

CountryUS (United States)

ATC code—

Dispensing—

ReimbursedNo

SourceFDA National Drug Code directory (United States)

Last synced6/3/2026

Packs · 4

ndc11
1422222511
1 JAR in 1 CARTON (14222-2251-1) / 30 mL in 1 JAR
ndc11
1422222512
1 JAR in 1 CARTON (14222-2251-2) / 7 mL in 1 JAR
ndc11
1422222513
2 mL in 1 PACKET (14222-2251-3)
ndc11
1422222514
1 JAR in 1 CARTON (14222-2251-4) / 15 mL in 1 JAR

Annotations

UNII (FDA Substance ID)

G63QQF2NOX

AVOBENZONE

RxCUI 45045

DailyMed SPL labels

1 version tracked

Raw payload (JSON)

{
  "unii": {
    "unii": "G63QQF2NOX",
    "rxcui": "45045",
    "inchikey": "XNEFYCZVKIDDMS-UHFFFAOYSA-N",
    "display_name": "AVOBENZONE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "TOPICAL",
  "spl_meta": {
    "d1dd62c6-33ac-4941-ab99-9eb8cc3c208a": {
      "match": "brand_token",
      "title": "REDEFINE TRIPLE DEFENSE (AVOBENZONE, OCTISALATE, OCTOCRYLENE) CREAM [RODAN & FIELDS]",
      "spl_version": "4",
      "published_date": "2026-02-05"
    }
  },
  "productid": "14222-2251_11ce87ce-001f-42c8-8420-b2e9463faf69",
  "productndc": "14222-2251",
  "dosage_form": "CREAM",
  "dea_schedule": null,
  "product_type": "HUMAN OTC DRUG",
  "substance_name": "AVOBENZONE; OCTISALATE; OCTOCRYLENE",
  "proprietary_name": "REDEFINE Triple Defense",
  "active_ingred_unit": "g/mL; g/mL; g/mL",
  "application_number": "M020",
  "marketing_category": "OTC MONOGRAPH DRUG",
  "nonproprietary_name": "AVOBENZONE, OCTISALATE, OCTOCRYLENE",
  "start_marketing_date": "20201018",
  "active_numerator_strength": ".03; .05; .07"
}

Access this data programmatically

Query REDEFINE Triple Defense and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.

Get a free API key Read the API docs